Dorsal Penile Nerve Block for Rigid Cystoscopy in Men

March 18, 2020 updated by: Yan Qiu, West China Hospital

Dorsal Penile Nerve Block for Rigid Cystoscopy in Men: a Single-center, Randomized, Double-blind and Placebo-controlled Study

This study will determine the effectiveness and safety of dorsal penile nerve block (DPNB) in men undergoing rigid cystoscopy.

Study Overview

Detailed Description

Pain is common in men undergoing rigid cystoscopy. Even with application of a lubricant containing 2% lidocaine, about 76% men suffer from mild to severe pain when undergoing rigid cystoscopy, and approximately 27% men could still feel mild to moderate pain 7 days after the procedure. The most painful part of the procedure for men is when the cystoscope passes through the membranous urethra. Song et al did autopsy on males found dorsal nerve of the penis (DNP), the terminal branch of the pudendal nerve, innervates the membranous urethra in 53.3% specimens. In addition, urethral mucosa has branches of DNP innervated. Dorsal penile nerve block (DPNB) is usually used for circumcision in children and it has been shown to provide effective analgesia for penile surgeries. According to the evidence that some DNP branches innervate membranous urethra and urethra mucosa and most pain originates from cystoscope passing through membranous urethra, we speculated that DPNB could overall reduce pain level in men during rigid cystoscopy.

Study Type

Interventional

Enrollment (Actual)

258

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sichuan
      • Chengdu, Sichuan, China, 610041
        • West China Hospital of Sichuan University, Department of Anesthesiology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 71 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • American Society of Anesthesiologists (ASA) Physical Status I-II
  • Without history of urethral or prostatic surgery
  • Without respiration or circulation disorders
  • Without chronic pain

Exclusion Criteria:

  • Allergy to local anesthetics
  • Coagulation disorder or usage of antiplatelet drugs
  • Infection at the site of puncture point
  • Severe urethral stenosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Tetracaine gel group
Dorsal penile nerve block with saline and tetracaine gel into urethra before rigid cystoscopy
1% Tetracaine gel instilled into urethra
Experimental: Dorsal penile nerve block group
Dorsal penile nerve block with ropivacaine and plain lubricating gel into urethra before rigid cystoscopy
Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
Experimental: Combination group
Dorsal penile nerve block with ropivacaine and tetracaine gel into urethra before rigid cystoscopy
1% Tetracaine gel instilled into urethra
Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale (VAS) for Pain
Time Frame: at cystoscopic inspection of external sphincter
A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.
at cystoscopic inspection of external sphincter

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale (VAS) for Pain
Time Frame: before gel administration
A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.
before gel administration
Visual Analog Scale (VAS) for Pain
Time Frame: at cystoscopic inspection of penile and bulbar urethra
A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.
at cystoscopic inspection of penile and bulbar urethra
Visual Analog Scale (VAS) for Pain
Time Frame: at cystoscopic inspection of prostate and bladder
A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.
at cystoscopic inspection of prostate and bladder
Visual Analog Scale (VAS) for Pain
Time Frame: after withdrawal of cystoscope
A visual analog scale (VAS) ranging from 0 to 10 was used to assess the patients' pain during the procedure. 0 means no pain, 1 to 3 means mild pain, 4 to 7 means moderate pain, and 8 to 10 means severe pain. Patients were asked the VAS score to express the degree of pain at each time point.
after withdrawal of cystoscope
Heart Rate Before Gel Administration
Time Frame: before gel administration
before gel administration
Heart Rate at Cystoscopic Inspection of Penile and Bulbar Urthra
Time Frame: at cystoscopic inspection of penile and bulbar urethra
at cystoscopic inspection of penile and bulbar urethra
Heart Rate at Cystoscopic Inspection of External Sphincter
Time Frame: at cystoscopic inspection of external sphincter
at cystoscopic inspection of external sphincter
Heart Rate After Withdrawal of Cystoscope
Time Frame: after withdrawal of cystoscope
after withdrawal of cystoscope
Mean Arterial Pressure Before Gel Administration
Time Frame: before gel administration
before gel administration
Mean Arterial Pressure at Cystoscopic Inspection of Penile and Bulbar Urthra
Time Frame: at cystoscopic inspection of penile and bulbar urthra
at cystoscopic inspection of penile and bulbar urthra
Mean Arterial Pressure at Cystoscopic Inspection of External Sphincter
Time Frame: at cystoscopic inspection of external sphincter
at cystoscopic inspection of external sphincter
Mean Arterial Pressure After Withdrawal of Cystoscope
Time Frame: after withdrawal of cystoscope
after withdrawal of cystoscope
Oxygen Saturation by Pulse Before Gel Administration
Time Frame: before gel administration
before gel administration
Oxygen Saturation by Pulse at Cystoscopic Inspection of Penile and Bulbar Urthra
Time Frame: at cystoscopic inspection of penile and bulbar urthra
at cystoscopic inspection of penile and bulbar urthra
Oxygen Saturation by Pulse at Cystoscopic Inspection of External Sphincter
Time Frame: at cystoscopic inspection of external sphincter
at cystoscopic inspection of external sphincter
Oxygen Saturation by Pulse After Withdrawal of Cystoscope
Time Frame: after withdrawal of cystoscope
after withdrawal of cystoscope
Breath Rate Before Gel Administration
Time Frame: before gel administration
before gel administration
Breath Rate at Cystoscopic Inspection of Penile and Bulbar Urthra
Time Frame: at cystoscopic inspection of penile and bulbar Urthra
at cystoscopic inspection of penile and bulbar Urthra
Breath Rate at Cystoscopic Inspection of External Sphincter
Time Frame: at cystoscopic inspection of external sphincter
at cystoscopic inspection of external sphincter
Breath Rate After Withdrawal of Cystoscope
Time Frame: after withdrawal of cystoscope
after withdrawal of cystoscope

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Guizhi Du, Doctor, West China Hospital of Sichuan University, Department of Anesthesiology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2015

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

July 6, 2015

First Submitted That Met QC Criteria

July 15, 2015

First Posted (Estimate)

July 20, 2015

Study Record Updates

Last Update Posted (Actual)

March 31, 2020

Last Update Submitted That Met QC Criteria

March 18, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Tetracaine

Subscribe